Memorializing Martin Y. Iguchi

Quarterly Insights from the RAND Drug Policy Research Center

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

May 2023

Two photos of Martin Y. Iguchi, one superimposed over the other, image by Kekeli Sumah/RAND Corporation

Memorializing the Pioneering Work and Dedicated Mentorship of Martin Y. Iguchi

This article memorializes Martin Y. Iguchi (1955-2021), former co-Director of the RAND DPRC, a pioneering clinical scientist, lifelong champion of equity and racial justice, and valued mentor to many of today's DPRC affiliates (including the current co-Directors). Read more »

ISSDP Conference Banner

Photo by RAND Europe

ISSDP Registration Reminder!

There’s still time to sign up for the sixteenth annual meeting of the International Society for the Study of Drug Policy (ISSDP) in Leuven, Belgium, from 30 May – 01 June 2023, at KU Leuven University. Please join us!

Read more »

Close up of a doctor consulting with a patient, photo by Chinnapong/Adobe Stock

Photo by Chinnapong/Adobe Stock

Trends in Geographic Proximity to Substance Use Disorder Treatment

Despite increases in the number of substance use disorder treatment facilities in rural areas, there has been less growth in nearby facilities offering evidence-based medication treatment for opioid use disorder.

Read more »

Maj. Laura Johnson, a mental health flight commander, speaks to an Airman in her office on June 10, 2021, at Malmstrom Air Force Base, Montana, photo by Heather Heiney/U.S. Air Force

Photo by Heather Heiney/U.S. Air Force

Behavioral Health Care Delivery Following the Onset of the COVID-19 Pandemic

RAND researchers examined changes in behavioral health care delivered to service members with PTSD, depression, or substance use disorder by the U.S. Military Health System following the onset of the COVID-19 pandemic, including patterns of care, use of telehealth, and quality of care.

Read More »

Trending Research

Illegal Opioids Are Hurting Too Many of Us. We Need a New Approach

Should Mexico's Drug Cartels Be Designated Foreign Terrorist Organizations?

A Randomized Trial of Letters to Encourage Prescription Monitoring Program Use and Safe Opioid Prescribing

DPRC in the News

Needing Younger Workers, Federal Officials Relax Rules on Past Drug Use

New York Times

Safety Net Clinics Still Rely on Audio-Only Telehealth

Axios

New X-Ray Checkpoints Scan for Fentanyl in Trucks at Mexico Border

Wall Street Journal

Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles

New York Times

Contact

Rosanna Smart

Rosanna Smart

Co-Director, RAND Drug Policy Research Center

Economist

Beau Kilmer

Beau Kilmer

Co-Director, RAND Drug Policy Research Center

McCauley Chair in Drug Policy Innovation

Mafalda Pardal

Mafalda Pardal

RAND Europe Lead, RAND Drug Policy Research Center

Senior Analyst